CIM Grand Rounds: Advancing the development of gene therapy for rare diseases

Peter Marks, M.D., Ph.D., discusses the advancement of gene therapies for rare diseases in the United States.

CIM Grand Rounds: A drug discovery platform for novel therapeutics against leishmaniasis and malaria

Ravi V. Durvasula, M.D., discusses a comprehensive exploration of a new drug discovery platform designed to tackle leishmaniasis and malaria.

Center for Individualized Medicine focus

The Center for Individualized Medicine's innovative "omics" strategy, powered by AI and structured around key pillars, is expected to enhance disease diagnosis, prognosis and treatment.

CIM Grand Rounds: Rare disease day 2024

Watch a special rare disease day webinar to hear from those on the front line in the fight against rare conditions, including the scientific, clinical, logistical and regulatory challenges in the field of individualized medicine.

CIM Grand Rounds: Translational justice and health disparities research in genomics

Megan A. Allyse, Ph.D. presents translational justice and health disparities research in genomics.

CIM Grand Rounds: Translating immunoregulatory approaches into the clinic

Bruce Blazar, M.D., discusses translation of immunoregulatory approaches into the clinic.

CIM Grand Rounds: Genomics for all of us

Josh Denny, M.D., M.S., discusses the All of Us Research Program from the National Institutes of Health.

CIM Grand Rounds: New advances in health monitoring

Michael Snyder, Ph.D., presents new advances in health monitoring.

Another promising application for stem cells: Crohn's complications

New research at Mayo Clinic is bringing hope to hundreds of thousands of people with Crohn's disease.

Grand Rounds: The Analytical Odyssey of the Diagnostic Odyssey

Eric W. Klee, Ph.D., and Patrick R. Blackburn, Ph.D., present The Analytical Odyssey of the Diagnostic Odyssey.